These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 75105)

  • 1. Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group.
    Alberto P; Rozencweig M; Gangji D; Brugarolas A; Cavalli F; Siegenthaler P; Hansen HH; Sylvester R
    Eur J Cancer (1965); 1978 Feb; 14(2):195-201. PubMed ID: 75105
    [No Abstract]   [Full Text] [Related]  

  • 2. Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
    Falkson G; Falkson HC; du Plessis HE; Meyer TE
    Cancer Clin Trials; 1980; 3(4):341-4. PubMed ID: 6159121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
    Kemeny N; Yagoda A; Burchenal JH
    Cancer Treat Rep; 1978 Mar; 62(3):463-4. PubMed ID: 77190
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclocytidine in breast cancer.
    O'Bryan RM; Baker L; Whitecar J; Salmon S; Vaughn C; Hoogstraten B
    Cancer Treat Rep; 1978 Mar; 62(3):455-6. PubMed ID: 77189
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluorinated Pyrimidine nucleosides. 1. Synthesis of a nitrogen analogue of the antitumor agent 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine hydrochloride.
    Cook AF
    J Med Chem; 1977 Mar; 20(3):344-8. PubMed ID: 66315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARA-C analogs.
    Alberto P
    Antibiot Chemother (1971); 1978; 23():88-98. PubMed ID: 348088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 1-11 study of DTIC and cyclocytidine in disseminated malignant melanoma.
    Samson MK; Baker LH; Izbicki RM; Ratanatharathorn V
    Cancer Treat Rep; 1976 Sep; 60(9):1369-71. PubMed ID: 65223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I-II evaluation of cyclocytidine.
    Burgess MA; Bodey GP; Minow RA; Gottlieb JA
    Cancer Treat Rep; 1977; 61(3):437-43. PubMed ID: 68828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I and II clinical study of anhydro-ara-5-fluorocytosine (AAFC) and ICRF-159 combination in adenocarcinoma of digestive origin.
    Brugarolas A; Buesa JM; Lacave AJ; Gracia Marco M; Valle Pereda M
    Cancer Clin Trials; 1978; 1(4):289-95. PubMed ID: 93030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of acute leukemia with cyclocytidine, with special reference to serum ara-C deaminase activity (author's transl)].
    Nakamura T; Sasada M; Sawada H; Higuchi T; Tatsumi K
    Nihon Ketsueki Gakkai Zasshi; 1977 Jun; 40(3):293-9. PubMed ID: 72473
    [No Abstract]   [Full Text] [Related]  

  • 11. Re-evaluation of methotrexate as an anticancer drug.
    Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
    Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and cytosine arabinoside in the treatment of murine brain tumor.
    Basler GA; Shapiro WR
    Cancer Treat Rep; 1976 Jul; 60(7):875-9. PubMed ID: 64295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation on the effect of cyclocytidine in herpes zoster of the eye].
    Ni RZ
    Zhonghua Yan Ke Za Zhi; 1984 Jul; 20(4):211-3. PubMed ID: 6210182
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trials referral resource. Clinical trials with taxol.
    Cheson BD
    Oncology (Williston Park); 1992 Mar; 6(3):67-70. PubMed ID: 1348954
    [No Abstract]   [Full Text] [Related]  

  • 15. Anguidine: a broad phase II study of the Southeastern Cancer Study Group.
    Adler SS; Lowenbraun S; Birch B; Jarrell R; Garrard J
    Cancer Treat Rep; 1984 Feb; 68(2):423-5. PubMed ID: 6697331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
    Burchenal JH; O'Toole T; Kalaher K; Chisholm J
    Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
    Meyers PA; Tan CT; Steinherz PG; Redner A
    Cancer; 1989 Dec; 64(12):2416-9. PubMed ID: 2479459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined 5-fluorouracil and vinblastine therapy for gastrointestinal and other solid tumors.
    al-Sarraf M; Vaughn CB; Reed ML; Vaitkevicious VK
    Oncology; 1972; 26(2):99-113. PubMed ID: 5049925
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of tissue distribution and fate of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and 1-beta-D-arabinofuranosyl-5-fluorocytosine in rats.
    Chou TC; Vidal P; Phillips FS
    Cancer Treat Rep; 1977 Jul; 61(4):617-24. PubMed ID: 69496
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
    Mertelsmann R; Drapkin RL; Gee TS; Kempin S; Passe S; Thaler HT; Arlin Z; Dowling M; Dufour P; McKenzie S; To L; Comacho E; Oettgen HF; Burchenal JH; Clarkson B
    Cancer; 1981 Nov; 48(10):2136-42. PubMed ID: 6170414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.